Ambulatory blood pressure and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease

Faruk Turgut1, Hüseyin Oflaz, Sule Namli

  • 1School of Medicine, Department of Internal Medicine, Division of Nephrology, Istanbul University, Capa, Istanbul, Turkey. farukturgut@yahoo.com

Renal Failure
|December 11, 2007
PubMed

Insights

Autosomal dominant polycystic kidney disease (ADPKD) patients who do not experience a nocturnal blood pressure dip have significantly impaired endothelial function. This endothelial dysfunction is linked to increased cardiovascular risks in ADPKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular disease is a leading cause of death in autosomal dominant polycystic kidney disease (ADPKD) patients.
  • Endothelial dysfunction (ED), an early sign of vascular damage, is observed in ADPKD.
  • The relationship between ambulatory blood pressure patterns and ED in ADPKD remains understudied.

Purpose of the Study:

  • To investigate the association between ambulatory blood pressure monitoring (ABPM) patterns and endothelial function in ADPKD patients.
  • To determine if non-dipper status in ADPKD is linked to endothelial dysfunction.

Main Methods:

  • Forty-one ADPKD patients with preserved renal function underwent 24-hour ABPM.
  • Patients were categorized into dipper and non-dipper groups based on nocturnal blood pressure decline.
  • Brachial artery endothelial function was assessed using high-resolution vascular ultrasound, measuring endothelial-dependent dilatation.

Main Results:

  • No significant differences in mean 24-hour systolic or diastolic blood pressure were found between dipper and non-dipper groups.
  • Non-dipper patients exhibited a significantly lower nocturnal fall rate in both systolic (0.98% vs. 11.1%) and diastolic (3.8% vs. 14.0%) blood pressure compared to dippers (p=0.001 for both).
  • Endothelial-dependent dilatation was significantly impaired in non-dippers (3.57%) compared to dippers (6.22%) (p=0.025).

Conclusions:

  • Non-dipper status in ADPKD is associated with significant endothelial dysfunction.
  • Impaired endothelial function in non-dipper ADPKD patients may contribute to increased cardiovascular morbidity and mortality.
  • ABPM and endothelial function assessment are crucial for cardiovascular risk stratification in ADPKD.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...